Macquarie Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.8K | Buy |
504
+290
| +136% | +$24.1K | ﹤0.01% | 1593 |
|
2025
Q1 | $17.4K | Sell |
214
-136
| -39% | -$11K | ﹤0.01% | 1595 |
|
2024
Q4 | $32 | Sell |
350
-610
| -64% | -$56 | ﹤0.01% | 1651 |
|
2024
Q3 | $94.8K | Sell |
960
-120,803
| -99% | -$11.9M | ﹤0.01% | 1584 |
|
2024
Q2 | $11.3M | Buy |
+121,763
| New | +$11.3M | 0.01% | 789 |
|
2018
Q2 | – | Sell |
-12,600
| Closed | -$1.11M | – | 2284 |
|
2018
Q1 | $1.11M | Sell |
12,600
-15,939
| -56% | -$1.4M | ﹤0.01% | 1154 |
|
2017
Q4 | $2.42M | Buy |
28,539
+15,939
| +127% | +$1.35M | ﹤0.01% | 975 |
|
2017
Q3 | $1.09M | Hold |
12,600
| – | – | ﹤0.01% | 1184 |
|
2017
Q2 | $972K | Buy |
+12,600
| New | +$972K | ﹤0.01% | 1172 |
|